MedPath

Valproate Sodium

Generic Name
Valproate Sodium

Overview

No overview information available.

Background

No background information available.

Indication

本品为全面性发作的首选药;也可用于部分性发作,Lennox-Gastaut综合征及热性惊厥;也可用于偏头痛及精神科主要用于双相情感障碍急性躁狂的治疗和预防,尤其适用快速循环和混合型,也适用于分裂情感障碍。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Sodium Valproate Oral Solution
国药准字H20243495
化学药品
口服溶液剂
7/30/2024
Sodium Valproate Oral Solution
国药准字H20203125
化学药品
口服溶液剂
3/24/2020
Sodium Valproate Oral Solution
国药准字H20234591
化学药品
口服溶液剂
12/5/2023
Sodium Valproate Oral Solution
国药准字H20249518
化学药品
口服溶液剂
12/1/2024
Sodium Valproate Oral Solution
国药准字H20244166
化学药品
口服溶液剂
6/28/2024
Sodium Valproate Oral Solution
国药准字H20233722
化学药品
口服溶液剂
6/14/2023
Sodium Valproate Oral Solution
国药准字HJ20170307
化学药品
口服溶液剂
10/20/2020
Sodium Valproate Oral Solution
国药准字H20243506
化学药品
口服溶液剂
4/17/2024
Sodium Valproate Oral Solution
国药准字H20233525
化学药品
口服溶液剂
5/12/2023
Sodium Valproate Oral Solution
国药准字H20041435
化学药品
口服溶液剂
6/5/2024

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath